Download
1 / 28
290 likes | 435 Views
Slide 1. Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting. Slide 2. Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting. Slide 3. Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting. Slide 4. Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting. Slide 5.
E N D
Slide 1 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Slide 2 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Slide 3 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Slide 4 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Slide 5 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Slide 6 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Slide 7 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Slide 8 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Slide 9 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Slide 10 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
EGFR Mutation Variant III (EGFRvIII) <br /> Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Epidermal Growth Factor Receptor Mutation (EGFRvIII) Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Epidermal Growth Factor Receptor Mutation (EGFRvIII) Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
EGFRvIII in GBM Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Rindopepimut (CDX-110)<br /> Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
ACTIVATE/ACT II Trial Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
<br />The Apparent Benefit from Rindopepimut<br /> Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
<br />ACT III Study Design<br /> Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
PFS from Diagnosis Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
OS from Diagnosis Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Immune Response and Outcome Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
<br />Nearly-Complete Response: GBM<br /> Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
<br />Elimination of EGFRvIII in Recurrent Tumor<br /> Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Conclusions Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Slide 25 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Slide 26 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Slide 27 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
Slide 28 Presented By Pedro Lowenstein at 2014 ASCO Annual Meeting
